What tests should I get after a Inflammatory Breast Cancer diagnosis

Testing After an Inflammatory Breast Cancer Diagnosis

After being diagnosed with inflammatory breast cancer (IBC), your care team will order several important tests to understand your cancer and plan your treatment. Here's what to expect:

Imaging Tests

According to the NCCN Guidelines for Patients: Inflammatory Breast Cancer, you'll likely have:

• Diagnostic mammogram - detailed x-ray pictures of both breasts to see the tumor size and extent
• Breast ultrasound and/or MRI - as needed to get a clearer picture of the affected breast
• Chest CT scan - to check if cancer has spread to your lungs (often with contrast dye injected into a vein)
• Abdominal/pelvic CT or MRI - to look for spread to organs in your abdomen
• Bone scan or PET/CT scan - to check if cancer has spread to your bones or other areas. An FDG-PET/CT scan is particularly helpful when other imaging results are unclear

Biopsy and Pathology Testing

• Skin biopsy - a small sample of the inflamed skin on your breast will likely be removed to confirm the IBC diagnosis

• Tumor tissue testing - your biopsy sample will be tested for:

  • ER/PR status (estrogen and progesterone receptors) - determines if hormones fuel your cancer
  • HER2 status - checks for a specific protein that affects treatment options
  • Grade - how the cancer cells look under a microscope
  • Other biomarkers - specific mutations like PIK3CA, AKT1, PTEN, ESR1, NTRK, and RET that may respond to targeted therapies
  • PD-L1 testing - an immune protein that helps predict response to immunotherapy
  • Tumor mutational burden (TMB) - the number of mutations in cancer cells
  • MSI-H/dMMR status - related to how well the body repairs DNA errors

• Sentinel lymph node biopsy (SNLB) - during surgery, the first lymph nodes where cancer is likely to spread are identified using a radioactive dye and removed to check for cancer cells

Blood Tests

Your care team will order:

• Complete blood count (CBC) - checks red blood cells, white blood cells, and platelets
• Comprehensive metabolic panel (CMP) - evaluates kidney and liver function
• Liver function tests (LFTs) - important since the liver is a common site for cancer spread
• Alkaline phosphatase (ALP) - can indicate bone or liver involvement
• Tumor markers - blood tests for proteins like CEA, CA 15-3, or CA 27.29 (though not everyone has elevated levels)
• Liquid biopsy - sometimes a blood test can detect circulating tumor DNA (ctDNA) from cancer cells

Other Important Assessments

• Medical history and physical exam - your care team will review your complete health history and do a thorough physical exam
• Medical photographs - pictures of your breast will be taken to document the appearance
• Genetic counseling and testing - if you have a family history of cancer or other risk factors, you may be referred for hereditary genetic testing (about 1 in 10 breast cancers are hereditary)
• Fertility assessment - discuss with your care team about fertility preservation options before treatment begins, as some treatments can affect your ability to have children

Questions to Ask Your Care Team

Based on NCCN guidelines, here are important questions:

1. What type of biopsy will I have, and will I need a skin biopsy?
2. What specific tests will be done on my tumor tissue, and when will results be ready?
3. What do my ER/PR and HER2 status mean for my treatment options?
4. Will you test for other mutations or biomarkers, and what will those tell us?
5. Do I need genetic testing based on my family history?
6. Should I see a fertility specialist before starting treatment?

Why These Tests Matter

These tests serve several purposes: they confirm the IBC diagnosis, determine how advanced the cancer is (staging), identify which treatments your specific cancer is likely to respond to, and establish a baseline to monitor how well treatment is working.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.